Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China–Myanmar border during 2008‒2017

Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China–Myanmar border during 2008‒2017

Background: Plasmodium vivax remains the predominant species at the China–Myanmar border, imposing a major challenge to the recent gains in regional malaria elimination. To closely supervise the emerging of drug resistance in this area, we surveyed the variations in genes potentially correlated with...

Full description

Bibliographic Details
Main Authors: Chen, Q. (Author), Ji, X. (Author), Pan, Y. (Author), Wang, H. (Author), Wang, Z. (Author), Wei, C. (Author), Zhang, L. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
antimalarial agent
Antimalarial drug
Antimalarials
biological marker
Biomarkers
China
China–Myanmar border
chloroquine
Chloroquine
drug resistance
Drug resistance
Drug Resistance
epidemiology
folic acid antagonist
Folic Acid Antagonists
genetics
human
Humans
Malaria, Vivax
Molecular marker
mutation
Mutation
Myanmar
parasitology
Plasmodium vivax
Plasmodium vivax malaria
protozoal protein
Protozoan Proteins
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items